About Argenta Discovery

Board

The Board of Argenta Discovery includes leading figures from the pharmaceutical industry, academia and the investment community.

Executive Directors

• Dr Christopher Ashton - Chief Executive Officer
• Dr Harry Finch - Executive VP, Therapeutics
• Dr Mary Fitzgerald - Executive VP, Respiratory
• Dr John Montana - Chief Scientific Officer
• Mr Colin Knox - Chief Financial Officer

Non-Executive Directors

• Mr Ian Kent - Chairman of the Board
• Professor A (Tony) G M Barrett - Glaxo Professor of Organic Chemistry, Imperial College of Science, Technology and Medicine, London
• Professor Alan Williamson - Scientific Advisor to the Board
• Dr Martin Murphy - MVM Life Science Partners LLP
• Renee Aguiar-Lucander - 3i Group plc
• Mr H Alexander (Sander) Slootweg - Forbion Capital Partners